Evidence Brief: Cost Savings

Lit review
by
Hyshka, Elaine et al

Release Date

2021

Geography

Canada

Language of Resource

English, French and Spanish

Full Text Available

Yes

Open Access / OK to Reproduce

No

Peer Reviewed

No

Objective

This evidence brief seeks to answer the question: are supervised consumption services (SCS) cost-effective measures?

Findings/Key points

All of the studies that were identified found that SCS save money. However, there is less agreement across the studies on exactly how much money is saved, and whether these savings can be directly attributed to SCS activities (as opposed to similar activities provided through other complementary services; e.g., needle distribution programs). Estimated savings resulting from Insite range from $200,000 to $6 million annually, depending on the modelling approach and variables included. Therefore, while there is a lack of agreement regarding the extent of the savings, the consensus is that Insite saves money overall.

Design/methods

This is a review of existing research on cost benefit analysis of SCS. It is unclear how many articles were included in their review, however a summarizing table of five articles are presented.

Keywords

Advocacy
Harm reduction
SCS/OPS